Oriola

What Oriola does

Oriola Oyj is a Finnish publicly listed health and wellbeing company (Nasdaq Helsinki: O5O/ORION) that operates a Nordic platform of three integrated service lines: Distribution Services, Wholesale Services, and Advisory Services. The company delivers GDP-compliant pharmaceutical and health product logistics, including specialized cold chain and vaccine distribution, to pharmaceutical manufacturers, pharmacies, healthcare providers, veterinarians, retailers, and e-commerce operators across Finland, Sweden, and Denmark. In 2024 Oriola delivered approximately 162 million pharmaceutical products through this network.

Underlying technology combines GDP-compliant supply chain infrastructure with modern cold chain capabilities, a research pharmacy network covering roughly one-fifth of all Finnish pharmacies, an ISO 17100-certified medical translations function, and a proprietary Oriola Insights market intelligence platform. In January 2026 Oriola began rolling out RELEX Solutions' AI-driven forecasting, replenishment, and diagnostics across its Nordic wholesale operations to reduce stockouts and automate replenishment, and in April 2026 it extended its Medical Information services into a scalable EU-wide model combining human scientific expertise with AI-enabled insights.

Revenue is generated through transaction-based distribution and wholesale fees on FY2025 net sales of EUR 1,906.2 million, plus quote-based multi-year B2B enterprise contracts for advisory work spanning market access, regulatory affairs, pharmacovigilance, clinical trials, medical translations, real-world evidence, and commercial services. GTM is enterprise field sales targeting pharma manufacturers plus channel partnerships with technology providers; the company had approximately 904 employees as disclosed on its website.

Name

Oriola

Legal name

Oriola Oyj

Website

https://oriola.com

Company type

Public

Founded year

2006

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Oriola is a publicly listed Nordic pharmaceutical distribution, wholesale, and advisory services company serving pharmaceutical manufacturers, pharmacies, healthcare providers, veterinarians, retailers, and e-commerce operators across Finland, Sweden, and Denmark.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution Services

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro industry

PRIMARYCRAOAHAB

OTC Medicines & Consumer Health Products Distribution

Consumer Products & Retail/Wholesale, Distribution & Category Management/Health, OTC & Pharmacy Wholesale Distribution

Keywords

• Pharmaceutical distribution
• Healthcare wholesale services
• Cold chain logistics
• Pharmaceutical advisory
• Nordic healthcare supply

Headquarters

HQ city

Espoo

HQ country

Finland

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Distribution Services: Revenue from pharmaceutical distribution services including quality control, warehousing, and logistics for pharmaceutical companies, pharmacies, and veterinarians. Net sales increased by 13.5% to EUR 1,906.2 million in 2025.
2. Wholesale Services: Revenue from connecting health and wellbeing suppliers and resellers through efficient, sustainable wholesale services with deep Nordic market knowledge and broad product range
3. Advisory Services: Revenue from tailored services across the entire product lifecycle including market entry, regulatory compliance, commercial strategy, market insights, clinical trial services, market access, tenders, and medical/regulatory affairs

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Oriola is a Nordic health and wellbeing company providing GDP-compliant pharmaceutical distribution, wholesale, and advisory services to pharmaceutical companies, pharmacies, healthcare providers, veterinarians, retailers, and e-commerce operators across Finland, Sweden, and Denmark. The company manages an integrated supply chain with modern cold chain technology and vaccine distribution expertise, complemented by lifecycle advisory services covering market entry, regulatory compliance, market access, medical information, clinical trials, and pharmacovigilance.

Product overview

Oriola is a Nordic health and wellbeing company operating as a platform of integrated services rather than a single unified product. The core portfolio consists of three main service lines: Distribution Services (GDP-compliant pharmaceutical and health product logistics including cold chain and vaccine distribution), Wholesale Services (connecting health product suppliers with pharmacies, retailers, and e-commerce), and Advisory Services (regulatory, market access, and commercial support for pharmaceutical companies). The Advisory Services module includes multiple specialized sub-modules such as Medical Information Services, Oriola Insights (market intelligence dashboards), Medical Translations (ISO 17100-certified), Research Services/RWE, Pharmacovigilance, Patient Support Programs, Clinical Trial Services, Market Access and Tenders, and Market Entry/Commercial Services. The distribution and wholesale services serve pharmaceutical companies, pharmacies, healthcare providers, veterinarians, retailers, and e-commerce across the Nordic market (Finland, Sweden, and Denmark).

Differentiator

Problem solved

Functional benefit

Products and services

• Distribution Services GDP-compliant pharmaceutical and health product distribution and logistics services in the Nordics, including quality control, warehousing, modern cold chain technology, and vaccine distribution expertise for pharmaceutical companies, pharmacies, healthcare providers, and veterinarians.
• Wholesale Services Nordic wholesale services connecting health and wellbeing suppliers and resellers with reliable access, local expertise, and streamlined operations through a broad, high-quality product range.
• Advisory Services Tailored services for pharmaceutical companies across the entire product lifecycle, from market entry and regulatory compliance to commercial strategy and market insights, combining deep knowledge of Nordic healthcare systems.
• Medical Information Services Next-generation Medical Information services combining human scientific expertise with AI-enabled insights, scalable EU-level delivery, and quality by design, supporting pharmaceutical companies across the Nordics and wider EU with multi-country coverage.
• Oriola Insights Real-time market analysis platform providing dashboards with Nordic healthcare data including drug reimbursement and resource utilization metrics, enabling data-driven decision making for Market Access, Medical, and Commercial teams.
• Medical Translations ISO 17100-certified medical translations to all Nordic languages, covering product information texts, patient materials, clinical study documentation, regulatory submissions, and health economic reports.
• Research Services (RWE) Real-World Evidence studies supporting decisions throughout the drug lifecycle, from national registry data to patient surveys conducted through the research pharmacy network in Finland and Sweden.
• Medical and Regulatory Affairs Regulatory affairs specialists and quality assurance services covering the entire lifecycle of human and veterinary medicines in Nordic markets, including market access, pricing, and reimbursement support.
• Market Access and Tenders Expert support for market entry, pricing, reimbursement, and procurement processes across Nordic healthcare systems, including health economic evaluations and HTA submissions.
• Pharmacovigilance Services Comprehensive drug safety services covering global, local, and clinical needs including EU QPPV provision, case management, quality management systems, risk management plans, and aggregate reporting.
• Patient Support Programs Patient support programs designed to improve treatment adherence through treatment support, education, home care services, and flexible service hours across Nordic countries.
• Clinical Trial Services Comprehensive clinical trial services in the Nordics and Baltics covering study logistics, regulatory consulting, site selection, monitoring, and coordination, including study drug logistics from receipt to destruction.
• Interim Solutions Flexible access to experienced pharmaceutical industry consultants for regulatory, drug safety, market entry, and other needs, providing specialist expertise without permanent recruitment costs.
• Market Entry and Commercial Services Market entry and sales support services for the Finnish market, including sales representatives, tailored launches, digital marketing to healthcare professionals, and pharmacy surveys.
• Dose Dispensing Dose dispensing services for pharmacies, organizing medication into unit-dose sachets or blister packs for easier patient administration and improved adherence.
• Research Pharmacy Network Network of research pharmacies (one-fifth of all Finnish pharmacies) participating in Real-World Evidence studies and patient-reported outcome data collection.
• Special Licensed Medicines Distribution services for special licensed medicines for pharmacies and veterinarians, handling products with special regulatory or handling requirements.

Quantifiable outcome

• 162 million pharmaceutical products delivered in 2024
• +3 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability11 records

Feature4 records

Partnerships

One partnership is on record.

• RELEX SolutionscoreTechnology or Integration · 5 January 2026Oriola selected RELEX Solutions to implement AI-driven forecasting, replenishment, and diagnostics capabilities across its Nordic wholesale distribution network. The implementation aims to improve supply chain visibility, optimize inventory levels, reduce stockouts, and automate manual replenishment processes across Oriola's logistics operations in Finland and Sweden. RELEX's technology helps Oriola handle its broad product portfolio with varying shelf lives while ensuring critical health products remain available to pharmacies, healthcare providers, and retailers.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Mediq: European distributor of medical devices and healthcare products to hospitals, pharmacies and care providers; directly comparable to Oriola's wholesale and distribution activities across European markets.
• Tamro: Finnish pharmaceutical distributor and wholesaler owned by Phoenix Group, directly competing with Oriola in pharmaceutical distribution and wholesale services in Finland and the Baltics.
• Alliance Healthcare: European pharmaceutical wholesaler and distributor (Walgreens Boots Alliance subsidiary) operating across multiple European markets, directly comparable to Oriola's distribution and wholesale service lines.

Broad incumbents

• Phoenix Group: Pan-European pharmaceutical wholesale and distribution group operating in 27 countries, including through its Tamro subsidiary; overlaps with Oriola's Nordic distribution and wholesale activities at much larger scale.
• McKesson: Global pharmaceutical distribution and healthcare services company; comparable to Oriola in core pharma distribution economics, though operating at vastly larger scale across North America and Europe.
• Cencora: Global pharmaceutical distribution and solutions provider (formerly AmerisourceBergen); comparable to Oriola's wholesale and distribution business model with similar thin-margin distribution dynamics at global scale.
• Cardinal Health: US-focused pharmaceutical distributor and healthcare services company; comparable in distribution model and operational economics to Oriola, though significantly larger and with different geographic focus.
• IQVIA: Global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry; overlaps with Oriola's advisory services, Oriola Insights market intelligence, and medical information offerings.
• Walgreens Boots Alliance: Integrated pharmacy, retail and pharmaceutical wholesale group (parent of Alliance Healthcare) operating global wholesale and distribution businesses comparable to Oriola's Nordic distribution model.

Regional players

• AAH Pharmaceuticals: UK's largest pharmaceutical wholesaler (part of Phoenix Group), serving pharmacies and hospitals with comparable distribution and wholesale services to Oriola but in a different geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/oriolacorporation

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A9 records

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oriola